| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Surinder K Batra | |
| Shantibhusan Senapati | |||
| Srustidhar Das | |||
| P2860 | cites work | Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response | Q24294875 |
| MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage | Q24298896 | ||
| The C-terminus of the transmembrane mucin MUC17 binds to the scaffold protein PDZK1 that stably localizes it to the enterocyte apical membrane in the small intestine | Q24299903 | ||
| MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met | Q24301503 | ||
| Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion | Q24301956 | ||
| Two-hybrid analysis of human salivary mucin MUC7 interactions | Q24337527 | ||
| Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin | Q24522854 | ||
| MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells | Q24630950 | ||
| Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier | Q24658379 | ||
| A binding domain on mesothelin for CA125/MUC16 | Q24658397 | ||
| Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors | Q24673454 | ||
| Molecular mapping of statherin- and histatin-binding domains in human salivary mucin MG1 (MUC5B) by the yeast two-hybrid system | Q28139450 | ||
| The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin | Q28142359 | ||
| MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion | Q28180863 | ||
| Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein | Q28203511 | ||
| DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7 | Q28204499 | ||
| MG2 and lactoferrin form a heterotypic complex in salivary secretions | Q28206394 | ||
| Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland | Q28208406 | ||
| Structure and biosynthesis of human salivary mucins | Q28216868 | ||
| Mucins in cancer: protection and control of the cell surface | Q28235006 | ||
| Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins | Q28235421 | ||
| Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion | Q28237260 | ||
| Cell surface-associated mucins in signal transduction | Q28257314 | ||
| MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90 | Q28271920 | ||
| Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein | Q28296763 | ||
| An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling | Q28582768 | ||
| MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. | Q31956559 | ||
| The cancer antigen CA125 represents a novel counter receptor for galectin-1. | Q34181115 | ||
| Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium | Q34341950 | ||
| MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling | Q34407038 | ||
| Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents | Q34440814 | ||
| The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop | Q34440854 | ||
| MUC1 is a novel regulator of ErbB1 receptor trafficking | Q34571022 | ||
| MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling | Q34572658 | ||
| Functions of MUC16 in corneal epithelial cells | Q34693932 | ||
| Gel-forming mucins appeared early in metazoan evolution. | Q36092589 | ||
| Intracellular MUC1 peptides inhibit cancer progression | Q37178708 | ||
| The cytoplasmic tail of MUC1: a very busy place | Q37210822 | ||
| The MUC gene family: their role in the diagnosis and prognosis of gastric cancer | Q37284927 | ||
| Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells | Q37290260 | ||
| Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. | Q37326840 | ||
| Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. | Q38307814 | ||
| Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment | Q39800430 | ||
| Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression | Q39961616 | ||
| Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells | Q40124709 | ||
| Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. | Q40133198 | ||
| MUC1 oncoprotein stabilizes and activates estrogen receptor alpha | Q40326798 | ||
| MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. | Q40345482 | ||
| MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells | Q40498647 | ||
| MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. | Q40550805 | ||
| MUC1 can interact with adenomatous polyposis coli in breast cancer | Q40578624 | ||
| Structure, biosynthesis, and function of salivary mucins | Q40585561 | ||
| Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells | Q40591851 | ||
| Involvement of the MAP kinase ERK2 in MUC1 mucin signaling | Q40798915 | ||
| Structural features of salivary function | Q40847177 | ||
| Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. | Q42991565 | ||
| MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation | Q47281356 | ||
| The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. | Q52543238 | ||
| MUC1 mucin core protein binds to the domain 1 of ICAM-1. | Q52828650 | ||
| The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer | Q71513108 | ||
| Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125) | Q80580929 | ||
| Transforming growth factor alpha dependent cancer progression is modulated by Muc1 | Q80635833 | ||
| Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis | Q81753531 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 236-245 | |
| P577 | publication date | 2009-11-11 | |
| P1433 | published in | Trends in Biochemical Sciences | Q1565711 |
| P1476 | title | Mucin-interacting proteins: from function to therapeutics | |
| P478 | volume | 35 |
| Q34193121 | A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier |
| Q34365646 | Altered Mucins (MUC) trafficking in benign and malignant conditions |
| Q36819304 | Analysis of tumor-associated mucin glycotopes by Western transfer methods |
| Q47410775 | Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor-specific inhibitor |
| Q35853834 | Autophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathway. |
| Q36283550 | Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy |
| Q36827374 | Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. |
| Q38908575 | Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. |
| Q37706759 | Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas |
| Q42734887 | Cigarette smoke disrupts the integrity of airway adherens junctions through the aberrant interaction of p120-catenin with the cytoplasmic tail of MUC1. |
| Q33812074 | Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function |
| Q33741303 | Cytotoxic efficacy of a novel dinuclear platinum(II) complex used with anti-MUC1 in human breast cancer cells. |
| Q35411163 | Efficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer |
| Q38058765 | Electrospun synthetic and natural nanofibers for regenerative medicine and stem cells. |
| Q35749993 | Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer. |
| Q57515385 | Engineering O-Glycosylation Points in Non-extended Peptides: Implications for the Molecular Recognition of Short Tumor-Associated Glycopeptides |
| Q41198201 | Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon |
| Q35904634 | Genetically engineered mucin mouse models for inflammation and cancer. |
| Q51219045 | Genetics of gastric cancer. |
| Q36700083 | Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models |
| Q36152246 | Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer |
| Q36857927 | Interaction of extravillous trophoblast galectin-1 and mucin(s)-Is there a functional relevance? |
| Q37520973 | MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression |
| Q33713506 | MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress |
| Q46407523 | MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis. |
| Q41790227 | Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments |
| Q41379077 | Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer |
| Q26764919 | Molecular alterations in gastric cancer with special reference to the early-onset subtype |
| Q40109841 | Muc1/Cd227 immunohistochemistry in routine practice is a useful biomarker in breast cancers. |
| Q39577860 | Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity |
| Q26861761 | Mucin-based targeted pancreatic cancer therapy |
| Q26830597 | Mucins and toll-like receptors: kith and kin in infection and cancer |
| Q90080269 | Mucins as a New Frontier in Pulmonary Fibrosis |
| Q35591546 | Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy |
| Q34500864 | Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. |
| Q34069612 | Pathobiological implications of MUC16 expression in pancreatic cancer |
| Q42212778 | Pivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitro |
| Q38258602 | Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer |
| Q47902181 | Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides. |
| Q59130268 | Probing into the Interaction of Nicotine and Bovine Submaxillary Mucin: NMR, Fluorescence, and FTIR Approaches |
| Q36896188 | Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy |
| Q91742289 | Role of MUC1 rs4072037 polymorphism in gastric cancer: a meta-analysis |
| Q35818749 | Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells |
| Q35846840 | Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation |
| Q59103157 | Specific MUC1 Splice Variants Are Correlated With Tumor Progression in Esophageal Cancer |
| Q27001592 | Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification |
| Q38922649 | Suppression of Toll-like receptor-mediated innate immune responses at the ocular surface by the membrane-associated mucins MUC1 and MUC16 |
| Q35741633 | Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer |
| Q58726271 | The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment |
| Q37338333 | The innate immune properties of airway mucosal surfaces are regulated by dynamic interactions between mucins and interacting proteins: the mucin interactome |
| Q47401476 | Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma. |
| Q55374172 | Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape. |
| Q37178423 | mRNA expression pattern of selected candidate genes differs in bovine oviductal epithelial cells in vitro compared with the in vivo state and during cell culture passages. |
Search more.